Evidence map›Paper›PMID 26455485›Full record

ReviewMethods (San Diego, Calif.)2016

Design, evaluation, and application of engineered skeletal muscle.

Mark Juhas, Jean Ye, Nenad Bursac

Abstract readReview
In one paragraph

Review in Methods (San Diego, Calif.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Available In Vitro Models for Human Satellite Cells from Skeletal Muscle.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. 3D Graphene Scaffolds for Skeletal Muscle Regeneration: Future Perspectives.Frontiers in bioengineering and biotechnology · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mark JuhasDepartment of Biomedical Engineering, Duke University, Durham, NC, United States.
Jean YeDepartment of Biomedical Engineering, Duke University, Durham, NC, United States.
Nenad BursacDepartment of Biomedical Engineering, Duke University, Durham, NC, United States. Electronic address: nbursac@duke.edu.

Funding

Translational studies of GAA deficiency in bioengineered human muscleR01AR065873 · NIAMS · DUKE UNIVERSITY · PI BURSAC, NENAD, KOEBERL, DWIGHT D · 2013 to 2017
$1.8M
Engineering a Functional Skeletal MuscleR01AR055226 · NIAMS · DUKE UNIVERSITY · PI BURSAC, NENAD · 2008 to 2012
$1.6M
NIAMS NIH HHS AR055226NIAMS NIH HHS AR065873NIAMS NIH HHS R01 AR055226NIAMS NIH HHS R01 AR065873
6 · The paper itself

Abstract

For over two decades, research groups have been developing methods to engineer three-dimensional skeletal muscle tissues. These tissues hold great promise for use in disease modeling and pre-clinical drug development, and have potential to serve as therapeutic grafts for functional muscle repair. Recent advances in the field have resulted in the engineering of regenerative muscle constructs capable of survival, vascularization, and functional maturation in vivo as well as the first-time creation of functional human engineered muscles for screening of therapeutics in vitro. In this review, we will discuss the methodologies that have progressed work in the muscle tissue engineering field to its current state. The emphasis will be placed on the existing procedures to generate myogenic cell sources and form highly functional muscle tissues in vitro, techniques to monitor and evaluate muscle maturation and performance in vitro and in vivo, and surgical strategies to both create diseased environments and ensure implant survival and rapid integration into the host. Finally, we will suggest the most promising methodologies that will enable continued progress in the field.

Indexed as

Tissue EngineeringAnimalsCell Culture TechniquesCells, CulturedHumansMuscle, SkeletalRegenerationRegenerative MedicineSatellite Cells, Skeletal MuscleStem Cell NicheAnimal implantationSatellite cellsSkeletal muscleTissue engineering

Identifiers

PMID26455485
PMCPMC4821818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.